MMP9 and glioblastoma: In summary, we developed a multifunctional peptide-based nanocarrierdesigned for mitochondria-targeted, MMP-9-responsive, and BBB-permeabledrug delivery, demonstrating a strong potential for effective andselective GBM treatment.